6-substituted-1,2,3,4-tetrahydroisoquinolines

Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514310, 546143, 546146, 546147, 546148, 546149, A61K 3147, C07D40906

Patent

active

049635638

ABSTRACT:
Compounds of the formula: ##STR1## wherein n=1 or 2; R.sub.1 is lower alkoxy, lower alkyl, halo, ester, carbamate, or substituted amino; and R.sub.2 is thienyl or furyl; or R.sub.2 is ##STR2## wherein R.sub.3 and R.sub.4 are independently selected from hydrogen, halo, hydroxy, methoxy, thioalkoxy, substituted amino and lower alkyl; and pharmaceutically acceptable salts thereof.
These compounds are useful as inhibitors of alpha-2-adrenergic receptors and for the treatment of glaucoma and/or controlling intraocular pressure.

REFERENCES:
patent: 4261998 (1981-04-01), Najer
patent: 4766131 (1988-08-01), Davidson et al.
patent: 4885302 (1989-12-01), George et al.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

6-substituted-1,2,3,4-tetrahydroisoquinolines does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with 6-substituted-1,2,3,4-tetrahydroisoquinolines, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 6-substituted-1,2,3,4-tetrahydroisoquinolines will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-850105

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.